Design, Synthesis and Biological Evaluation of Potent Human Glyoxalase I Inhibitors

Several glutathione derivatives bearing the S-(N-aryl-N-hydroxycarbamoyl) or S-(C-aryl-N-hydroxycarbamoyl) moieties (10, 10′, 13–15) were synthesized, characterized, and their human glyoxalase I (hGLO1) inhibitory activity was evaluated. Compound 10 was proved to be the effective hGLO1 inhibitor wit...

Full description

Saved in:
Bibliographic Details
Published inChemical & pharmaceutical bulletin Vol. 65; no. 5; pp. 455 - 460
Main Authors Jin, Tian, Zhai, Jing, Liu, Xiao, Yue, Yan, Huang, Maolin, Li, Zonghe, Ni, Caixia, Deng, Qishan, Sang, Yankui, Yao, Zhongwei, Zhang, Hong, Hu, Xiaopeng, Zheng, Zhe-Bin
Format Journal Article
LanguageEnglish
Published TOKYO The Pharmaceutical Society of Japan 01.05.2017
Pharmaceutical Society of Japan
Pharmaceutical Soc Japan
Japan Science and Technology Agency
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Several glutathione derivatives bearing the S-(N-aryl-N-hydroxycarbamoyl) or S-(C-aryl-N-hydroxycarbamoyl) moieties (10, 10′, 13–15) were synthesized, characterized, and their human glyoxalase I (hGLO1) inhibitory activity was evaluated. Compound 10 was proved to be the effective hGLO1 inhibitor with a Ki value of 1.0 nM and the inhibition effect of compound 10 on hGLO1 was nearly ten-fold higher than that of the strongest inhibitor 2 (Ki=10.0 nM) which has been reported in the field of glutathione-type hGLO1 inhibitors. Its diethyl ester prodrug 10′ was able to penetrate cell membrane and had good inhibitory effect on the growth of NCI-H522 cell xenograft tumor model.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0009-2363
1347-5223
DOI:10.1248/cpb.c16-00800